WHO approves clinical trials for two new Ebola vaccines

Summary

The World Health Organization on Wednesday approved clinical trials for two new Ebola vaccines, designed for the Bundibugyo virus, a strain that currently has no approved vaccine. The approval comes as doctors work to control an outbreak in Africa, mainly in the DR Congo, that has killed more than 5,300 people. Reports say the trials could offer new hope in the fight against the outbreak.

Timeline

1. Euronews

   4 Nov 2026, 17:06 UTCSource ↗

   Euronews reports that WHO backed trials for two new vaccines, which could offer new hope against an Ebola outbreak caused by a strain with no approved vaccine.

2. RTÉ

   4 Nov 2026, 17:13 UTCSource ↗

   RTÉ reports that WHO has approved clinical trials for two new Ebola vaccines as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.

3. RTÉ

   4 Nov 2026, 17:13 UTCSource ↗

   RTÉ reports in a second article that WHO has approved clinical trials for two new Ebola vaccines as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.

4. Al Jazeera

   4 Nov 2026, 19:22 UTCSource ↗

   Al Jazeera reports that two new vaccines designed for the Bundibugyo virus, which has killed more than 5,300 people in the DR Congo, have been approved for trials by WHO.

5. Africanews

   4 Nov 2026, 20:09 UTCSource ↗

   Africanews reports that WHO on Wednesday approved clinical trials for two new Ebola vaccines as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.